CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest
Balance, shares at Dec. 31, 2021		19,695,532
Balance, amount at Dec. 31, 2021	$ 2,867,660	$ 19,696	$ 6,321,428	$ (3,459,214)	$ (14,250)
Warrant valuation expense	437,375	$ 0	437,375	0	0
Issuance of common stock, shares		208,000
Issuance of common stock, amount	416,000	$ 208	415,792	0	0
Offering costs paid in connection with sale of common stock	(76,525)	$ 0	(76,525)	0	0
Common stock issued for convertible note, shares		56,592
Common stock issued for convertible note, amount	56,591	$ 56	56,535	0	0
Net loss attributable to non-controlling interests	0	0	0	1,583	(1,583)
Net loss for the six months ended June 30, 2022	(974,566)	$ 0	0	(974,566)	0
Balance, shares at Jun. 30, 2022		19,960,124
Balance, amount at Jun. 30, 2022	2,726,535	$ 19,960	7,154,605	(4,432,197)	(15,833)
Balance, shares at Mar. 31, 2022		19,695,532
Balance, amount at Mar. 31, 2022	2,411,819	$ 19,696	6,742,803	(4,336,197)	(14,483)
Issuance of common stock, shares		208,000
Issuance of common stock, amount	416,000	$ 208	415,792	0	0
Common stock issued for convertible note, shares		56,592
Common stock issued for convertible note, amount	56,591	$ 56	56,535	0	0
Net loss attributable to non-controlling interests	0	0	0	1,350	(1,350)
Net loss for the six months ended June 30, 2022	(97,350)	0	0	(97,350)	0
Offering costs	(60,525)	$ 0	(60,525)	0	0
Balance, shares at Jun. 30, 2022		19,960,124
Balance, amount at Jun. 30, 2022	2,726,535	$ 19,960	7,154,605	(4,432,197)	(15,833)
Balance, shares at Dec. 31, 2022		23,436,505
Balance, amount at Dec. 31, 2022	7,560,199	$ 23,436	18,095,184	(10,463,048)	(95,373)
Issuance of common stock, shares		4,830,000
Issuance of common stock, amount	7,245,000	$ 4,830	7,240,170	0	0
Common stock issued for convertible note, shares		62,223
Common stock issued for convertible note, amount	29,032	$ 62	28,970	0	0
Net loss attributable to non-controlling interests	0	0	0	47,894	(47,894)
Net loss for the six months ended June 30, 2022	(3,989,904)	0	0	(3,989,904)	0
Offering costs	(634,600)	$ 0	(634,600)	0	0
Shares issued for consulting services, shares		15,000
Shares issued for consulting services, amount	12,900	$ 15	12,885	0	0
Capitalized value of warrants	374,453	$ 0	374,453	0	0
Capital contribution related to joint venture	1,000		1,000
Balance, shares at Jun. 30, 2023		28,343,728
Balance, amount at Jun. 30, 2023	10,598,080	$ 28,343	25,118,062	(14,405,058)	(143,267)
Balance, shares at Mar. 31, 2023		28,281,505
Balance, amount at Mar. 31, 2023	12,179,368	$ 28,281	25,088,092	(12,828,649)	(108,356)
Common stock issued for convertible note, shares		62,223
Common stock issued for convertible note, amount	29,032	$ 62	28,970	0	0
Net loss attributable to non-controlling interests	0	0	0	34,911	(34,911)
Net loss for the six months ended June 30, 2022	(1,611,320)	0	0	(1,611,320)	0
Capital contribution related to joint venture	1,000	$ 0	1,000	0	0
Balance, shares at Jun. 30, 2023		28,343,728
Balance, amount at Jun. 30, 2023	$ 10,598,080	$ 28,343	$ 25,118,062	$ (14,405,058)	$ (143,267)